CooperCompanies stock holds near USD 69.59 as investors await September 9 earnings update
Published on 09/08/2026 at 11:23 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
CooperCompanies stock (ISIN US21664P1039) is trading at USD 69.59 on the Nasdaq as of September 4, 2026, roughly 15.1% below the USD 81.96 level seen at the beginning of 2026, leaving investors focused on the upcoming earnings release on September 9, 2026 and the company’s ability to reignite growth.MarketBeat
Earnings on September 9 and consensus expectations
According to market data compiled by MarketBeat, CooperCompanies is scheduled to report its next earnings on September 9, 2026, a date that has become the key near term catalyst for the stock as investors reassess growth prospects and valuation in light of recent trading around the USD 69.59 mark as of September 4, 2026.
An earnings preview on finanzen.ch highlights that analysts on average expect CooperCompanies to deliver earnings per share of USD 1.12 for the quarter ended July 31, 2026, compared with USD 0.49 per share in the prior year quarter, implying a jump of around 128.6% in quarterly EPS if the consensus is met in full.
Revenue growth and full year outlook
The same analyst survey cited by finanzen.ch points to expected quarterly revenue of USD 1.10 billion for CooperCompanies for the three months to July 31, 2026, up from USD 1.06 billion in the comparable quarter of the prior year, corresponding to revenue growth of 3.59% year on year if the forecasts prove accurate.
For the full fiscal year, which analysts classify as fiscal year 2026, expectations compiled in the preview suggest that CooperCompanies could reach revenue of roughly USD 4.31 billion, compared with USD 4.09 billion generated in the prior year, a projected increase of about 5.4% that would extend the mid single digit growth trend if delivered.finanzen.ch
Analyst ratings, price targets and valuation
Market data assembled by MarketBeat show that CooperCompanies currently carries a consensus analyst price target of USD 81.64, representing approximately 17.3% upside from the USD 69.59 share price level recorded as of September 4, 2026, indicating that analysts on balance still see room for appreciation despite the year to date decline.
The same overview reports that CooperCompanies’ stock was trading at USD 81.96 at the beginning of 2026 and has since decreased by 15.1% to USD 69.59, underscoring that the upcoming earnings release is set against a backdrop of a double digit retreat from earlier levels even as the company remains within its 52 week trading range between USD 58.89 and USD 89.83.MarketBeat
Institutional positioning and recent filings
A recent alert from MarketBeat notes that institutional investors collectively own around 24.39% of CooperCompanies’ shares, with recent regulatory filings highlighting activity such as Nykredit A S purchasing 28,865 shares, signaling continued institutional engagement even as the share price consolidates near the lower half of its yearly range.
Additional filings summarized by MarketBeat point out that HSBC Holdings PLC has grown its stake in The Cooper Companies, Inc., with the same data provider reiterating that the stock opened at USD 69.59 on the referenced Tuesday session and trades with a 50 day moving average price of USD 72.67 and a 200 day moving average price of USD 70.28, levels that frame the current consolidation ahead of the September 9, 2026 earnings date.
Market capitalization and trading range
According to figures from CompaniesMarketCap, CooperCompanies has a market capitalization of USD 13.57 billion as of early September 2026, based on a share price of USD 69.59 and Nasdaq data, placing the company among the world’s roughly 1,600 most valuable listed firms by market cap.
The same dataset highlights that CooperCompanies’ shares have traded between a fifty two week low of USD 58.89 and a fifty two week high of USD 89.83, meaning that the current USD 69.59 level as of September 4, 2026 positions the stock about 18.1% above the low and around 22.5% below the high, a range that investors may view as offering both recovery potential and downside risk depending on the strength of upcoming results.MarketBeat
Upcoming earnings call and calendar
An earnings calendar entry on CNBC includes CooperCompanies among companies scheduled to report after the bell in the relevant holiday shortened trading week, aligning with the September 9, 2026 reporting date cited by other sources and reinforcing that the earnings release, followed by the conference call, is the immediate focal point for market participants.
Additionally, a preview article from Yahoo Finance notes that CooperCompanies, described as a medical device company listed on Nasdaq under the ticker COO, will report earnings after market close on the stated Wednesday, with the article referencing a current share price around USD 70.30 and an average analyst price target of USD 81.50, broadly consistent with the consensus range seen in other datasets.
Product and business focus
CooperCompanies is widely regarded as a global medical device company headquartered in San Ramon, California, with operations primarily in specialty contact lenses and women’s health products, and the company’s portfolio spans vision correction solutions and fertility related devices that align with long term secular trends in eye care and reproductive health.MarketBeat
CooperCompanies stock price and trading venue
CooperCompanies’ primary listing is on the Nasdaq, where the stock trades under the ticker COO in United States dollars; the most recent widely cited closing price is USD 69.59 as of September 4, 2026, with investors monitoring intraday fluctuations around this level as they position ahead of the September 9, 2026 earnings release and assess whether the forthcoming data can justify the consensus price targets that stand in the low 80 dollar range.MarketBeat
CooperCompanies stock key data
- Company: CooperCompanies, Inc.
- ISIN: US21664P1039
- Ticker: COO
- Trading venue: Nasdaq
- Price (as of September 4, 2026, 16:00): 69.59 USD
- Market capitalization: 13.57 billion USD (as of September 6, 2026)
- Sector / Industry: Health Care / Medical Devices
- Index membership: S&P 500
- Next earnings date: September 9, 2026
